Page 40 - Read Online
P. 40

RFA of HCC, and 5 by WR. Two patients were subjected to   repeat hepatectomies in the treatment of primary or secondary
          a third repeat procedure consisting of laparoscopic WR of   tumors of the liver. [1-5]  At present, studies on laparoscopic
          segment II and VI, respectively, for a second recurrence of   hepatic re-interventions are limited. Technical difficulties
          liver metastases.                                   of both repeat hepatectomy and laparoscopic approach
                                                              have slowed the spread of laparoscopic re-interventions on
          The laparoscopic procedure was successfully completed in   the liver. Few papers are available on this procedure, and
          23 cases (95.9%). Adhesions were graded by the staff surgeons   investigations are biased due to the retrospective nature
          using the scale presented in Table 3, similar to that used in a   of these studies, and to the time differences between the
          multi-center study on adhesion prevention.  Grades 3 and 4   series of open and laparoscopic interventions [Table 4]. [6,15-22]
                                             [10]
          adhesions were present in 5 patients (71.4%) in Group 1 and
          2 patients (11.7%) in the Group 2.                  Tsuchiya et al.  reported a cohort of 14 patients affected by
                                                                         [20]
                                                              HCC, who underwent laparoscopic repeat resection after a
          Of the 24 patients, one underwent conversion to laparotomy   primary procedure (laparoscopic hepatectomy, RFA, resection
          in Group 1, not because of adhesions but due to inadequate   of extrahepatic metastasis, or diagnostic assessment).
          control of the resection margin for a HCC located in   They demonstrated that 2-year survival in patients with
          segment IV. One patient, receiving a   laparoscopic RFA of   intrahepatic recurrence (100%) is significantly higher than in
          a HCC of 28 mm in VII segment after primary intervention   those with the extrahepatic recurrence (42.9%).
          of segmentectomy associated with laparoscopic RFA, was
          subjected to intestinal resection associated with ileostomy   Indeed, the surgical strategy can be changed, and survival
          to treat peritonitis from intestinal perforation that occurred
          during laparoscopic RFA.                            can be impaired because of the presence of concomitant
                                                              peritoneal recurrence or because of extensive peritoneal
          The mean operative time for re-intervention was significantly   adhesiolysis. Biopsies of suspicious lesions are mandatory
          longer for Group 1 (220.14 ± 80.06 min) than for    to identify carcinomatous foci in dense adhesions to treat
          Group 2 (150 ± 56.18 min; P = 0.001), whereas the mean   the extrahepatic recurrence if possible, or to abstain from a
          blood loss was comparable in both groups: 297 ± 134 mL   surgical procedure.
          in Group 1 and 272.2 ± 120 mL in Group 2 (P > 0.05).
                                                                        [18]
          The mean hospital stay was 6.4 ± 2.5 days in Group 1 and   Shafaee et al.  analyzed the experience of laparoscopic repeat
          5.2 ± 3 days in Group 2 (P > 0.05). The resection margins   liver resection of three institutions recruiting 76 patients (61
          were disease-free in all the patients.              with liver metastasis, 3 with HCC, and 12 with benign lesions)
                                                              divided into two groups according to the first surgical
          The overall post-operative morbidity and mortality rates were   approach. Peri-operative outcomes (in terms of estimated
          29.1% (7/24) and 0%, respectively. According to Dindo-Clavien   blood loss and intra-operative transfusions) were better in
          classification,  overall morbidity varied between Grades I   patients with previous LRs than in patient with previous
                     [11]
          and IIIa. Morbidity rate was 29.4% in Group 1 and 28.5% in   ORs. Furthermore, long-term outcomes in terms of hepatic
          Group 2. In Group 1, 2 patients had atelectasis treated by   recurrence and the need for laparoscopic re-interventions
          physical therapy (Clavien’s Grade II), 2 had pneumonia treated   were compared with those of open repeat resection in other
          by antibiotics (Clavien’s Grade II) and 1 had bleeding from   studies, [1-5]  and similar outcomes were observed.
          one trocar site treated by compression (Clavien’s Grade II). In
          Group 2, 1 patient presented post-operatively with moderate   Table 4: Retrospective studies about laparoscopic repeat
          ascites, 1 with atelectasis (Clavien’s Grade I) and 1 presented   surgery of the liver
          with intestinal perforation that occurred during a laparoscopic   Year  Author    Number Tumor
          RFA, requiring a re-intervention (Clavien’s Grade IIIa).  2009  Belli et al. [6]  12 cases  HCC
                                                              2009  Liang et al. [15]        1 case  HCC
          Long-term outcomes in terms of hepatic recurrence have not   2010  Cheung et al. [16]  1 case  HCC
          yet been evaluated.                                 2011  Hu et al. [17]          6 cases  HCC
                                                                             [18]
                                                              2011  Shafaee et al.  (tri-institutional)  76 cases HCC + metastasis
                                                              2011  Nakahira et al. [19]    15 cases  HCC + metastasis
          DISCUSSION
                                                              2012  Tsuchiya et al. [20]    16 cases  HCC
                                                              2013  Kanazawa et al. [21]    40 cases HCC
          Recurrence rate for liver malignancy is estimated at   2014  Shelat et al. [22]   19 cases HCC + metastasis
          77-100% for HCC [12,13]  and 60% for metastasis from colorectal   2015  Cioffi  et al. (this series)  24 cases HCC + metastasis
          carcinoma.  Nevertheless, current data report efficacy of   HCC: hepatocellular carcinoma
                   [14]
               Hepatoma Research | Volume 1 | Issue 1 | April 15, 2015                                       33
   35   36   37   38   39   40   41   42   43   44   45